hVIVO plc 2016 Annual Report and Financial Statements (6926D)
28 Avril 2017 - 3:00PM
UK Regulatory
TIDMHVO
RNS Number : 6926D
hVIVO plc
28 April 2017
For immediate release 2.00pm: 28 April 2017
HVIVO PLC
("hVIVO" or the "Company")
2016 Annual Report and Financial Statements
hVIVO plc (AIM: HVO), a specialty biopharma company with
clinical testing capabilities, is pleased to announce that its
Annual Report and Financial Statements for the year ended 31
December 2016 is being posted to shareholders today. It will be
available on the Company's website
(http://hvivo.com/investors/financial-reports/) from 4.30 pm
today.
For further information please contact:
hVIVO plc +44 207 756 1300
Kym Denny (Chief Executive
Officer)
Graham Yeatman (Chief Financial
& Business Officer)
+44 203 021 3933
/
Media Enquiries +44 7854 979 420
Colin Paterson (Director of
Marketing, Communication and
Public Relations)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Michael Burke
(Corporate Broking)
FTI Consulting
Simon Conway / Victoria Foster
Mitchell (UK) +44 203 727 1000
John Capodanno / Evan Smith
(US) +1 212 850 5705
Notes to Editors:
hVIVO plc ("hVIVO"), a specialty biopharma company with
discovery and clinical testing capabilities, is pioneering a
human-based analytical platform to accelerate drug discovery and
development in respiratory and infectious diseases. Leveraging
human disease models in flu, RSV and asthma exacerbation, the hVIVO
platform captures disease in motion, illuminating the entire
disease life cycle from healthy to sick and back to health. Based
in the UK, market leader hVIVO has conducted more than 45 clinical
studies, inoculated over 2000 volunteers and has three
first-in-class therapies currently in development with a growing
pre-clinical pipeline.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSOKFDNCBKKAQB
(END) Dow Jones Newswires
April 28, 2017 09:00 ET (13:00 GMT)
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Août 2023 à Août 2024